Skip to main content
. 2020 Jul 17;40(7):BSR20194468. doi: 10.1042/BSR20194468

Figure 5. The expression levels and survival prognosis of SNHG15 in cancers via accessing the GEPIA cohort.

Figure 5

cholangiocarcinoma, colonadenocarcinoma, lymphoid neoplasm diffuse large B-cell lymphoma, kidney renal clear cell carcinoma, acute myeloid leukemia (A). pancreatic adenocarcinoma, rectum adenocarcinoma, testicular germ cell tumors, thyroid carcinoma and thymoma were revealed in (B). Survival plots in the GEPIA cohort via merging the expression data of SNHG15 and OS (C) (n=9502). Survival plots in the GEPIA cohort via merging the expression data of SNHG15 and DFS (D) (n=9502).